Cubist Systematic Strategies’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $85.7K | Sell |
63,484
-94,720
| -60% | -$107K | ﹤0.01% | 2793 |
|
|
2025
Q2 | $150K | Buy |
158,204
+144,407
| +1,047% | +$93.6K | ﹤0.01% | 2654 |
|
|
2025
Q1 | $6.36K | Buy |
+13,797
| New | +$8.71K | ﹤0.01% | 2769 |
|
|
2024
Q2 | – | Sell |
-1,404,928
| Closed | -$3.37M | – | 3734 |
|
|
2024
Q1 | $3.37M | Buy |
+1,404,928
| New | +$3.02M | 0.04% | 1239 |
|
|
2023
Q3 | – | Sell |
-179,327
| Closed | -$411K | – | 3752 |
|
|
2023
Q2 | $411K | Buy |
179,327
+173,405
| +2,928% | +$460K | ﹤0.01% | 2503 |
|
|
2023
Q1 | $14.4K | Sell |
5,922
-12,323
| -68% | -$28.2K | ﹤0.01% | 3695 |
|
|
2022
Q4 | $34.8K | Sell |
18,245
-4,600
| -20% | -$9.79K | ﹤0.01% | 3946 |
|
|
2022
Q3 | $55K | Buy |
+22,845
| New | +$63.2K | ﹤0.01% | 4114 |
|
|
2022
Q2 | – | Sell |
-10,816
| Closed | -$23K | – | 4461 |
|
|
2022
Q1 | $23K | Sell |
10,816
-55,992
| -84% | -$155K | ﹤0.01% | 3469 |
|
|
2021
Q4 | $263K | Buy |
66,808
+22,204
| +50% | +$108K | ﹤0.01% | 2891 |
|
|
2021
Q3 | $215K | Buy |
+44,604
| New | +$183K | ﹤0.01% | 2548 |
|
|
2021
Q2 | – | Sell |
-12,943
| Closed | -$76K | – | 3013 |
|
|
2021
Q1 | $76K | Sell |
12,943
-32,104
| -71% | -$222K | ﹤0.01% | 2689 |
|
|
2020
Q4 | $154K | Buy |
+45,047
| New | +$85.9K | ﹤0.01% | 2331 |
|
|
2019
Q4 | – | Sell |
-42,879
| Closed | -$129K | – | 2493 |
|
|
2019
Q3 | $129K | Buy |
+42,879
| New | +$133K | ﹤0.01% | 1885 |
|
|
2019
Q2 | – | Sell |
-20,828
| Closed | -$116K | – | 2528 |
|
|
2019
Q1 | $116K | Buy |
20,828
+10,156
| +95% | +$61.7K | ﹤0.01% | 1960 |
|
|
2018
Q4 | $71K | Sell |
10,672
-6,700
| -39% | -$54.3K | ﹤0.01% | 1816 |
|
|
2018
Q3 | $185K | Sell |
17,372
-11,033
| -39% | -$126K | 0.01% | 1436 |
|
|
2018
Q2 | $341K | Buy |
28,405
+2,373
| +9% | +$24.3K | 0.02% | 1003 |
|
|
2018
Q1 | $223K | Buy |
26,032
+4,569
| +21% | +$42.3K | 0.01% | 1335 |
|
|
2017
Q4 | $212K | Buy |
21,463
+9,321
| +77% | +$96.8K | 0.01% | 1494 |
|
|
2017
Q3 | $149K | Buy |
+12,142
| New | +$179K | 0.01% | 1543 |
|
|
2017
Q2 | – | Sell |
-14,055
| Closed | -$202K | – | 1796 |
|
|
2017
Q1 | $202K | Buy |
+14,055
| New | +$209K | 0.01% | 1178 |
|
|
2016
Q4 | – | Sell |
-17,292
| Closed | -$312K | – | 1813 |
|
|
2016
Q3 | $312K | Buy |
+17,292
| New | +$278K | 0.02% | 990 |
|
|
2015
Q3 | – | Sell |
-13,814
| Closed | -$111K | – | 1940 |
|
|
2015
Q2 | $111K | Sell |
13,814
-286
| -2% | -$2.1K | 0.01% | 1605 |
|
|
2015
Q1 | $93K | Sell |
14,100
-14,643
| -51% | -$100K | ﹤0.01% | 1679 |
|
|
2014
Q4 | $183K | Buy |
+28,743
| New | +$232K | 0.01% | 1546 |
|
Other funds holding LXRX
AG
SL
SC